Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase
- PMID: 8606154
- PMCID: PMC177875
- DOI: 10.1128/jb.178.7.1821-1828.1996
Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase
Abstract
Beta-Lactamase is a bacterial protein that provides resistance against beta-lactam antibiotics. TEM-1 beta-lactamase is the most prevalent plasmid-mediated beta-lactamase in gram-negative bacteria. Normally, this enzyme has high levels of hydrolytic activity for penicillins, but mutant beta-lactamases have evolved with activity toward a variety of beta-lactam antibiotics. It has been shown that active site substitutions are responsible for changes in the substrate specificity. Since mutant beta-lactamases pose a serious threat to antimicrobial therapy, the mechanisms by which mutations can alter the substrate specificity of TEM-1 beta-lactamase are of interest. Previously, screens of random libraries encompassing 31 of 55 active site amino acid positions enabled the identification of the residues responsible for maintaining the substrate specificity of TEM-1 beta-lactamase. In addition to substitutions found in clinical isolates, many other specificity-altering mutations were also identified. Interestingly, many nonspecific substitutions in the N-terminal half of the active site omega loop were found to increase ceftazidime hydrolytic activity and decrease ampicillin hydrolytic activity. To complete the active sight study, eight additional random libraries were constructed and screened for specificity-altering mutations. All additional substitutions found to alter the substrate specificity were located in the C-terminal half of the active site loop. These mutants, much like the N-terminal omega loop mutants, appear to be less stable than the wild-type enzyme. Further analysis of a 165-YYG-167 triple mutant, selected for high levels of ceftazidime hydrolytic activity, provides an example of the correlation which exists between enzyme instability and increased ceftazidime hydrolytic activity in the ceftazidime-selected omega loop mutants.
Similar articles
-
A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.J Biol Chem. 2015 Apr 17;290(16):10382-94. doi: 10.1074/jbc.M114.633438. Epub 2015 Feb 20. J Biol Chem. 2015. PMID: 25713062 Free PMC article.
-
Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.Mol Microbiol. 1994 Apr;12(2):217-29. doi: 10.1111/j.1365-2958.1994.tb01011.x. Mol Microbiol. 1994. PMID: 8057847
-
Cephalosporin substrate specificity determinants of TEM-1 beta-lactamase.J Biol Chem. 1997 Nov 14;272(46):29144-50. doi: 10.1074/jbc.272.46.29144. J Biol Chem. 1997. PMID: 9360991
-
Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.Front Mol Biosci. 2018 Feb 23;5:16. doi: 10.3389/fmolb.2018.00016. eCollection 2018. Front Mol Biosci. 2018. PMID: 29527530 Free PMC article. Review.
-
Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.Mol Microbiol. 1990 Oct;4(10):1615-20. doi: 10.1111/j.1365-2958.1990.tb00537.x. Mol Microbiol. 1990. PMID: 2077352 Review.
Cited by
-
RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution.BMC Biotechnol. 2007 Apr 11;7:18. doi: 10.1186/1472-6750-7-18. BMC Biotechnol. 2007. PMID: 17425805 Free PMC article.
-
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0044722. doi: 10.1128/aac.00447-22. Epub 2022 Aug 18. Antimicrob Agents Chemother. 2022. PMID: 35980232 Free PMC article. Review.
-
Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.mBio. 2019 Jul 2;10(4):e00405-19. doi: 10.1128/mBio.00405-19. mBio. 2019. PMID: 31266860 Free PMC article.
-
β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.RSC Med Chem. 2021 Aug 4;12(10):1623-1639. doi: 10.1039/d1md00200g. eCollection 2021 Oct 20. RSC Med Chem. 2021. PMID: 34778765 Free PMC article. Review.
-
Predicting the viability of beta-lactamase: How folding and binding free energies correlate with beta-lactamase fitness.PLoS One. 2020 May 29;15(5):e0233509. doi: 10.1371/journal.pone.0233509. eCollection 2020. PLoS One. 2020. PMID: 32470971 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous